HIV molecular immunology database
NAACAWLEAQEEEEVGFPVT
|
Nef(52-71) | human epitope |
WLEAQEEEEVGFPVR
|
Nef(57-71) | human epitope |
WLRAQEEEEEVGFPVRPQV
|
Nef(57-74) | C*06 human epitope |
WLEAQEEEEVGFPVRPQV
|
Nef(57-74) | human epitope |
WLEAQEEDSDVGFPVRPQV
|
Nef(57-74) | human epitope |
WLEAQEEDSeVGFPVRPQV
|
Nef(57-74) | observed variant |
WLEAQEEEEVGFPVRPQV
|
Nef(57-74) | human epitope |
QEEEEVGFPVRPQVP
|
Nef(61-75) | B57 human epitope |
QEEEEVGFPVRPQVP
|
Nef(61-75) | human epitope |
QEEEEVGFPVRPQVPLRPMT
|
Nef(61-80) | human epitope |
EEEEVGFPVR
|
Nef(62-71) | A*02, B*45 human epitope |
EEEEVGFPVTPQVPLRPMTY
|
Nef(62-81) | human epitope |
EEEEVGFVTPQVPLRPMTY
|
Nef(62-81) | human epitope |
EEEEVGFPVTPQVPLRPMTY
|
Nef(62-81) | human epitope |
EEEEVGFPVTPQVPLRPMTY
|
Nef(62-81) | human epitope |
EEGVGFPVRPQ
|
Nef(63-73) | B*45:01 human epitope |
EEEVGFPVKPQVPLR
|
Nef(63-77) | B7 human epitope |
EEEVGFPVRPQVPLR
|
Nef(63-77) | human epitope |
EEEVGFPVRPQVPLR
|
Nef(63-77) | human epitope |
GEVGFPVRPQV
|
Nef(64-74) | B45 human epitope |
EEVGFPVRPQV
|
Nef(64-74) | B*45:01 human epitope |
EEVGFPVRPQV
|
Nef(64-74) | B*45:01 human epitope |
EEVGFPVKPQV
|
Nef(64-74) | B*45:01 human epitope |
dEVGFPVKPQV
|
Nef(64-74) | diminished response; escape documented in this paper |
dEVGFPVrPQV
|
Nef(64-74) | diminished response; escape documented in this paper |
gEVGFPVrPQV
|
Nef(64-74) | susceptible form |
EEVGFPVRPQV
|
Nef(64-74) | human epitope |
EEVGFPVRPQV
|
Nef(64-74) | human epitope |
EEVGFPVKPQV
|
Nef(64-74) | human epitope |
EVGFPVRPQVPL
|
Nef(65-76) | human epitope |
EVGFPiRPQVPL
|
Nef(65-76) | observed variant |
gVGFPVRPQVPL
|
Nef(65-76) | observed variant |
EmGFPVRPQVPL
|
Nef(65-76) | observed variant |
kVGFPVRPQVPL
|
Nef(65-76) | observed variant |
EVGFPVRPQVPLRPM
|
Nef(65-79) | human epitope |
EVGFPVRPQVPLRPM
|
Nef(65-79) | human epitope |
EVGFPVRPQVPLRPMTFK
|
Nef(65-82) | C*03, C*04, C*12 human epitope |
EVGFPVRPQVPLRPMTYK
|
Nef(65-82) | human epitope |
EVGFPVRPQVPLRPMTYK
|
Nef(65-82) | human epitope |
EVGFPVRPQVPLRPMTYK
|
Nef(65-82) | human epitope |
EVGFPVRPQVPLRPMTfK
|
Nef(65-82) | subtype-specific susceptible form |
DVGFPVRPQVPLRPMTYK
|
Nef(65-82) | human epitope |
eVGFPVRPQVPLRPMTYK
|
Nef(65-82) | observed variant |
EVGFPVRPQVPLRPMTYK
|
Nef(65-82) | human epitope |
EVGFPVtPQVPLRPMTYK
|
Nef(65-82) | observed variant |
VGFPVRPQV
|
Nef(66-74) | A*02:01 human epitope |
VGFPVRPQV
|
Nef(66-74) | human epitope |
VGFPVTPQVPLRMT
|
Nef(66-80) | A1, B8 human epitope |
VGFPVTPQVPLRMT
|
Nef(66-80) | A1, B8 human epitope |
VGFPVTPQVPLRPMTYK
|
Nef(66-82) | A*11:01 human epitope |
VGFPVTPQVPLRPMTYKAAVDLSHFLKEKGGL
|
Nef(66-97) | human epitope |
GFPVRPQVPLRPMTY
|
Nef(67-81) | human epitope |
GFPVRPQVPLRPMTY
|
Nef(67-81) | human epitope |
GFPVRPQVPLRPMTY
|
Nef(67-81) | human epitope |
FPVTPQVPL
|
Nef(68-76) | A*68:02 human epitope |
FPVTPQVPL
|
Nef(68-76) | B*07 human epitope |
FPVTPQVPL
|
Nef(68-76) | B*07 human epitope |
FPVTPQVPL
|
Nef(68-76) | B*07 human, transgenic mouse epitope |
FPVTPQVPL
|
Nef(68-76) | B*07 human epitope |
FPVRPQVPL
|
Nef(68-76) | B*07:02 human epitope |
FSVRPQVPL
|
Nef(68-76) | susceptible form |
FPARPQVPL
|
Nef(68-76) | susceptible form |
SPVRPQVPL
|
Nef(68-76) | susceptible form |
FPIRPQVPL
|
Nef(68-76) | observed variant |
FPVTPQVPL
|
Nef(68-76) | B*07:02 human epitope |
FPVRPQVPL
|
Nef(68-76) | B*07:02 human epitope |
FPVKPQVPL
|
Nef(68-76) | B*07:02 human epitope |
FPVRPQVPL
|
Nef(68-76) | B*07:02 human epitope |
FPVkPQVPL
|
Nef(68-76) | inferred escape; literature escape |
FPVRPQVPL
|
Nef(68-76) | B*07:02 human epitope |
FPVRPQVPL
|
Nef(68-76) | B*07:02 human epitope |
FPVKPQVPL
|
Nef(68-76) | B*07:02 human epitope |
FPVrPQVPL
|
Nef(68-76) | non-susceptible form; susceptible form |
FPVtPQVPL
|
Nef(68-76) | diminished response; escape documented in this paper; non-susceptible form; susceptible form |
FPVRPQVPL
|
Nef(68-76) | B*07:02 human epitope |
FPVkPQVPL
|
Nef(68-76) | diminished response; escape documented in this paper; non-susceptible form |
FPVkPQVPv
|
Nef(68-76) | diminished response; escape documented in this paper; non-susceptible form |
FPVkPrVPL
|
Nef(68-76) | diminished response; escape documented in this paper; non-susceptible form |
FPVkPQVsL
|
Nef(68-76) | diminished response; escape documented in this paper; non-susceptible form |
FPVtPQVPL
|
Nef(68-76) | diminished response; escape documented in this paper; non-susceptible form |
FPVtPQVPv
|
Nef(68-76) | diminished response; escape documented in this paper; non-susceptible form |
FPVtPrVPL
|
Nef(68-76) | diminished response; escape documented in this paper; non-susceptible form |
FPVRPQVPL
|
Nef(68-76) | B*35 human epitope |
FPVRPQVPL
|
Nef(68-76) | B*35 human epitope |
FPVkPQVPL
|
Nef(68-76) | susceptible form |
FPVTPQVPL
|
Nef(68-76) | B*35 human epitope |
FPVRPQVPL
|
Nef(68-76) | B35 human epitope |
FPVRPQVPL
|
Nef(68-76) | B35 human epitope |
FPVRPQVPL
|
Nef(68-76) | B35 human epitope |
FPVTPQVPL
|
Nef(68-76) | B35 human epitope |
FPVKPQVPL
|
Nef(68-76) | B35, B7 human epitope |
FPVKPQVPL
|
Nef(68-76) | B35, B7 human epitope |
FPVRPQVPL
|
Nef(68-76) | B*35:01 human epitope |
FPVRPQVPL
|
Nef(68-76) | B*35:01 human epitope |
FPVRPQVPL
|
Nef(68-76) | B*35:01 human epitope |
FPVRPQVPL
|
Nef(68-76) | B*35:01, B7 human epitope |
FPVRPQVPL
|
Nef(68-76) | B7 human epitope |
FPVRPQVPL
|
Nef(68-76) | B7 human epitope |
FPVRPQVPL
|
Nef(68-76) | B7 human epitope |
FPVtPQVPL
|
Nef(68-76) | observed variant |
FPVTPQVPL
|
Nef(68-76) | B7 human epitope |
FPVTPQVPL
|
Nef(68-76) | B7 human epitope |
FPVTPQVPL
|
Nef(68-76) | B7 supertype human epitope |
FPVRPQVPL
|
Nef(68-76) | B7 supertype human, mouse epitope |
FPVRPQVPL
|
Nef(68-76) | human epitope |
FPVtPQVPL
|
Nef(68-76) | escape documented in this paper |
FPVkPQVPL
|
Nef(68-76) | diminished response |
FPVKPQVPL
|
Nef(68-76) | human epitope |
FPVrPQVPL
|
Nef(68-76) | susceptible form |
FPVTPQVPLR
|
Nef(68-77) | A*68:02 human epitope |
FPVTPQVPLR
|
Nef(68-77) | B*07 human, transgenic mouse epitope |
FPVrPQVPLR
|
Nef(68-77) | non-susceptible form |
FPVTPQVPLR
|
Nef(68-77) | B*07 human epitope |
FPVTPQVPLR
|
Nef(68-77) | B*07 human epitope |
FPVTPQVPLR
|
Nef(68-77) | B*07, B*35 human epitope |
FPVKPQVPLR
|
Nef(68-77) | B*07:02 human epitope |
FPVrPQVPLR
|
Nef(68-77) | non-susceptible form |
FPVtPQVPLR
|
Nef(68-77) | diminished response; escape documented in this paper; non-susceptible form |
FPVTPQVPLR
|
Nef(68-77) | B*07:02 human epitope |
FPVTPQVPLR
|
Nef(68-77) | B*07:02 human epitope |
FPVRPQVPLR
|
Nef(68-77) | B*07:02 human epitope |
FPVkPQVPLR
|
Nef(68-77) | diminished response; escape documented in this paper; non-susceptible form |
FPVkPQVPvR
|
Nef(68-77) | diminished response; escape documented in this paper; non-susceptible form |
FPVkPQePLi
|
Nef(68-77) | diminished response; escape documented in this paper; non-susceptible form |
FPVtPQVPLR
|
Nef(68-77) | diminished response; escape documented in this paper; non-susceptible form |
FPVtPQVPLt
|
Nef(68-77) | diminished response; escape documented in this paper; non-susceptible form |
FPVTPQVPLR
|
Nef(68-77) | B7 human epitope |
FPVRPQVPLR
|
Nef(68-77) | B7 human epitope |
FPVTPQVPLR
|
Nef(68-77) | B7 human epitope |
FPVTPQVPLR
|
Nef(68-77) | B7 human epitope |
FPVTPQVPLR
|
Nef(68-77) | B7 human epitope |
FPVTPQVPLR
|
Nef(68-77) | B7 human epitope |
FPVTPQVPLR
|
Nef(68-77) | B7 human epitope |
FPVRPQVPLR
|
Nef(68-77) | B7 human epitope |
FPVtPQVPLR
|
Nef(68-77) | observed variant |
FPVRPQVPLR
|
Nef(68-77) | B7 human epitope |
FPVTPQVPLR
|
Nef(68-77) | B*81 human epitope |
FPVRPQVPLR
|
Nef(68-77) | human epitope |
FPVkPQVPLR
|
Nef(68-77) | altered HLA expression |
FPVTPQVPLR
|
Nef(68-77) | human epitope |
FPVTPQVPLR
|
Nef(68-77) | human epitope |
FPVTPQVPLRMTY
|
Nef(68-81) | human epitope |
FPVrPQVPLRMTY
|
Nef(68-81) | observed variant |
FPVkPQVPLRMTY
|
Nef(68-81) | observed variant |
FPVTPQVPLRPMTFK
|
Nef(68-82) | A3 human epitope |
FPVRPQVPLRPMTYK
|
Nef(68-82) | A3 human epitope |
FPVRPQVPLRPMTYK
|
Nef(68-82) | B35 human epitope |
FPVRPOVPLRPMTYK
|
Nef(68-82) | human epitope |
FPVRPQVPLRPMTYKGA
|
Nef(68-84) | human epitope |
FPVRPQVPLRPMTYKaA
|
Nef(68-84) | observed variant |
PVKPQVPLR
|
Nef(69-77) | human epitope |
PVRPQVPLRPMTYKA
|
Nef(69-83) | human epitope |
PVRPQVPLRPMTfKA
|
Nef(69-83) | observed variant |
VTPQVPLRPMTYKAA
|
Nef(70-84) | human epitope |
TPQVPLRPM
|
Nef(71-79) | A*30 human epitope |
TPQVPLRPM
|
Nef(71-79) | A*34 human epitope |
TPQVPLRPM
|
Nef(71-79) | A*68:02 human epitope |
TPQVPLRPM
|
Nef(71-79) | B*07 human epitope |
RPQVPLRPM
|
Nef(71-79) | B*07 human epitope |
TPQVPLRPM
|
Nef(71-79) | B*07 human epitope |
RPQVPLRPM
|
Nef(71-79) | B*07, B*81:01 human epitope |
TPQVPLRPM
|
Nef(71-79) | B*07:02 human epitope |
RPQVPLRPM
|
Nef(71-79) | B*07:02 human epitope |
kPQVPLRPM
|
Nef(71-79) | inferred escape |
RPQVPLRPM
|
Nef(71-79) | B*07:02 human epitope |
RPQVPLRPM
|
Nef(71-79) | B*07:02, B*42:01, B*81:01, B7, B81 human epitope |
RPQVPLRPM
|
Nef(71-79) | B*07:02, B*81:01 human epitope |
RPQVPLRPM
|
Nef(71-79) | B*07:02, B*81:01 human epitope |
RPQVPvRPM
|
Nef(71-79) | altered HLA expression; observed variant; replicative capacity reduced |
TPQVPLRPM
|
Nef(71-79) | B*35 human epitope |
TPQVPLRPM
|
Nef(71-79) | B35 human epitope |
RPQVPLRPM
|
Nef(71-79) | B*35:01 human epitope |
RPQVPLRPM
|
Nef(71-79) | B*35:02, B*35:03, B*53:01 human epitope |
RPQVPLRPM
|
Nef(71-79) | B*39 human epitope |
RPQVPLRPM
|
Nef(71-79) | B*42 human epitope |
RPQVPLRPM
|
Nef(71-79) | B*42 human epitope |
RPQVPLRPM
|
Nef(71-79) | B42 human epitope |
TPQVPLRPM
|
Nef(71-79) | B42 human epitope |
RPQVPLRPM
|
Nef(71-79) | B*42:01 human epitope |
RPQVPLRPM
|
Nef(71-79) | B*42:01 human epitope |
RPQVPLRPM
|
Nef(71-79) | B*42:01 human epitope |
RPQVPLRPM
|
Nef(71-79) | B*42:01 human epitope |
RPQVPLRPM
|
Nef(71-79) | B*42:01 human epitope |
RPQVPLRPM
|
Nef(71-79) | B*42:01 human epitope |
RPQVPLRPM
|
Nef(71-79) | B*42:01 human epitope |
RPQVPLRPM
|
Nef(71-79) | B*42:01, B*42:02 human epitope |
RPQQVPLRPM
|
Nef(71-79) | B*42:01, B*81:01 human epitope |
RPQVPLRPM
|
Nef(71-79) | B*42:02 human epitope |
RPQVPLRPM
|
Nef(71-79) | B*42:02 epitope |
RPQVPLRPM
|
Nef(71-79) | B7 human epitope |
tPQVPLRPM
|
Nef(71-79) | observed variant |
TPQVPLRPM
|
Nef(71-79) | B7 human epitope |
TPQVPLRPM
|
Nef(71-79) | B7 human epitope |
TPQVPLRPM
|
Nef(71-79) | B7 human epitope |
TPQVPLRPM
|
Nef(71-79) | B7 human epitope |
TPQVPLRPM
|
Nef(71-79) | B7 human epitope |
TPQVPLRPM
|
Nef(71-79) | B7 human epitope |
TPQVPLRPM
|
Nef(71-79) | B7 human epitope |
TPQVPLRPM
|
Nef(71-79) | B7 human epitope |
TPQVPLRPM
|
Nef(71-79) | B7 human epitope |
RPQVPLRPM
|
Nef(71-79) | B*78 human epitope |
TPQVPLRPM
|
Nef(71-79) | B*78 human epitope |
TPQVPLRPM
|
Nef(71-79) | B7 supertype human epitope |
RPQVPLRPM
|
Nef(71-79) | B*81 human epitope |
RPQVPLRPM?
|
Nef(71-79) | B81 human epitope |
RPQVPLRPM
|
Nef(71-79) | B*81:01 human epitope |
RPQVPvRPM
|
Nef(71-79) | literature escape |
RPQaPLRPM
|
Nef(71-79) | observed variant |
kPQVPLRPM
|
Nef(71-79) | observed variant |
RPQVPiRPM
|
Nef(71-79) | literature escape |
RPQVPtRPM
|
Nef(71-79) | literature escape |
RPQVPLRPM
|
Nef(71-79) | B*81:01 human epitope |
RPQVPLRPM
|
Nef(71-79) | B*81:01 human epitope |
RPQVPvRPM
|
Nef(71-79) | calculated escape |
RPQVPtRPM
|
Nef(71-79) | observed variant |
RPQVPmRPM
|
Nef(71-79) | observed variant |
RPQmPLRPM
|
Nef(71-79) | observed variant |
kPQVPvRPM
|
Nef(71-79) | observed variant |
RPQVPiRPM
|
Nef(71-79) | observed variant |
tPQVPIRPM
|
Nef(71-79) | observed variant |
RPQVPLRPM
|
Nef(71-79) | B*82 human epitope |
RPQVPLRPM
|
Nef(71-79) | C*04 human epitope |
RPQVPLRPM
|
Nef(71-79) | C*17 human epitope |
RPQVPLRPM
|
Nef(71-79) | human epitope |
RPQVPLRPM
|
Nef(71-79) | human epitope |
kPQVPLRPM
|
Nef(71-79) | susceptible form |
tPQVPLRPM
|
Nef(71-79) | observed variant |
RPQVPvRPM
|
Nef(71-79) | escape documented in this paper |
RPQVPtRPM
|
Nef(71-79) | escape documented in this paper |
tPQVPLkPM
|
Nef(71-79) | observed variant |
RPQaPLRPM
|
Nef(71-79) | observed variant |
RPQVPmRPM
|
Nef(71-79) | observed variant |
kPQVPvRPM
|
Nef(71-79) | observed variant |
RPQmPLRPM
|
Nef(71-79) | observed variant |
RPQVPiRPM
|
Nef(71-79) | escape documented in this paper |
cPQVPLRPM
|
Nef(71-79) | observed variant |
RPQVrLRPM
|
Nef(71-79) | observed variant |
RPQVlLRPM
|
Nef(71-79) | observed variant |
TPQVPLRPMTY
|
Nef(71-81) | B*07, B*35 human epitope |
RPQVPLRPMTY
|
Nef(71-81) | B*35 human epitope |
tPQVPLRPMTY
|
Nef(71-81) | diminished response |
RPQVPLRPMTY
|
Nef(71-81) | B*35 human epitope |
RPQVPLRPMTf
|
Nef(71-81) | susceptible form |
tPQVPLRPMTY
|
Nef(71-81) | escape documented in this paper |
tPQVPLRPMTf
|
Nef(71-81) | observed variant |
RPQVPLRPMTY
|
Nef(71-81) | B*35 human epitope |
RPQVPLRPMTY
|
Nef(71-81) | B35 human epitope |
kPQVPLRPMTY
|
Nef(71-81) | altered HLA expression; observed variant; replicative capacity reduced |
TPQVPLRPMTY
|
Nef(71-81) | B35 human epitope |
RPQVPLRPMTY
|
Nef(71-81) | B35 human epitope |
RPQVPLRPMTY
|
Nef(71-81) | B35 human epitope |
tPQVPLRPMTY
|
Nef(71-81) | escape documented in this paper; TCR related mutation |
RPQVPLRPMTY
|
Nef(71-81) | B35 human epitope |
RPQVPLRPMTf
|
Nef(71-81) | susceptible form |
RPQVPLRPMTY
|
Nef(71-81) | B35 human epitope |
tPQVPLRPMTY
|
Nef(71-81) | escape documented in this paper |
tPQVPLRPMTf
|
Nef(71-81) | escape documented in this paper |
RPQVPLRPMTY
|
Nef(71-81) | B35 human epitope |
RPQVPLRPMTY
|
Nef(71-81) | B35 human epitope |
RPQVPLRPMTY
|
Nef(71-81) | B*35:01 human epitope |
RPQVPLRPMTY
|
Nef(71-81) | B*35:01 human epitope |
RPQVPLRPMTY
|
Nef(71-81) | B*35:01 human epitope |
RPQVPLRPMTf
|
Nef(71-81) | observed variant; replicative capacity is not abrogated |
kPQVPLRPMTY
|
Nef(71-81) | observed variant; replicative capacity is not abrogated |
RPQVPLRPMdY
|
Nef(71-81) | observed variant; replicative capacity is not abrogated |
RPQVPLRPMTY
|
Nef(71-81) | B*35:01 human epitope |
RPQVPLRPMTY
|
Nef(71-81) | B*35:01 human epitope |
tPQVPLRPMTY
|
Nef(71-81) | escape documented in this paper |
tPQVPLRPMTf
|
Nef(71-81) | escape documented in this paper |
RPQVPLRPMTY
|
Nef(71-81) | B*35:01 human epitope |
RPQVPLRPMTY
|
Nef(71-81) | B51 human, macaque epitope |
TPQVPLRPMTY
|
Nef(71-81) | B7 human epitope |
TPQVPLRPMTY
|
Nef(71-81) | B7 supertype human epitope |
rPQVPLRPMTY
|
Nef(71-81) | susceptible form |
RPQVPLRPMTY
|
Nef(71-81) | human epitope |
RPQVPLRaMTY
|
Nef(71-81) | HLA association |
KPQVPLRPMTYKAAV
|
Nef(71-85) | A3, B35 human epitope |
RPQVPLRPMTYKAAL
|
Nef(71-85) | human epitope |
RPQVPLRPMTYKAAL
|
Nef(71-85) | human epitope |
RPQVPLRPMTYKAAL
|
Nef(71-85) | human epitope |
RPQVPLRPMTYKAAVDLSHF
|
Nef(71-90) | human epitope |
PQVPLRPMTY
|
Nef(72-81) | B35 human epitope |
PQVPLRPMTY
|
Nef(72-81) | B35, B51 human epitope |
PQVPLRPMTY
|
Nef(72-81) | B*51 human epitope |
PQVPLRPMTYKGAFD
|
Nef(72-86) | human epitope |
PQVPLRMTYKAAVDLSHFL
|
Nef(72-91) | human epitope |
PQVPLRPMTYKAAVDLSHFL
|
Nef(72-91) | human epitope |
PQVPLRRMTYKAAVDLSHFL
|
Nef(72-91) | human epitope |
QVPLRPMTY
|
Nef(73-81) | A1 human epitope |
QVPLRPMTY
|
Nef(73-81) | A*80:01 human epitope |
QVPLRPMTY
|
Nef(73-81) | B*07 human epitope |
QVPLRPMTY
|
Nef(73-81) | B*35 human epitope |
QVPLRPMTY
|
Nef(73-81) | B*35:01 human epitope |
QVPLRPMTY
|
Nef(73-81) | human epitope |
QVPvRPMTY
|
Nef(73-81) | susceptible form |
QaPLRPMTY
|
Nef(73-81) | non-susceptible form; susceptible form |
QVPLRPMTf
|
Nef(73-81) | non-susceptible form; susceptible form |
QVPaRPMTY
|
Nef(73-81) | non-susceptible form; susceptible form |
QVPLRaMTY
|
Nef(73-81) | non-susceptible form; susceptible form |
QVPLaPMTY
|
Nef(73-81) | non-susceptible form; susceptible form |
QVPLRPMTYK
|
Nef(73-82) | A*02:01 human epitope |
QVPLRPMTYK
|
Nef(73-82) | A*02:01 human epitope |
QVPLRPMTYK
|
Nef(73-82) | A*03 human epitope |
QVPLRPMTYK
|
Nef(73-82) | A*03 human epitope |
QVPLRPMTYK
|
Nef(73-82) | A*03 human epitope |
QVPLRPMTYK
|
Nef(73-82) | A*03 human epitope |
QVPLRPMTYK
|
Nef(73-82) | A*03 human epitope |
QVPLRPMTYK
|
Nef(73-82) | A*03 human epitope |
QVPLRPMTYK
|
Nef(73-82) | A*03, A*11, A*31, B*27, B*35 human epitope |
QVPLRPMTYK
|
Nef(73-82) | A*03:01 human epitope |
QVPLRPMTYK
|
Nef(73-82) | A*03:01 human epitope |
QVPLRPMTYK
|
Nef(73-82) | A*03:01 human epitope |
QVPLRPMTYK
|
Nef(73-82) | A*03:01 human epitope |
QVPLRPMTYK
|
Nef(73-82) | A*03:01 human epitope |
QVPLRPMTYK
|
Nef(73-82) | A*03:01 human epitope |
QiPLRPMTYK
|
Nef(73-82) | susceptible form |
QVPLaPMTYK
|
Nef(73-82) | diminished response |
QVPLgPMTYK
|
Nef(73-82) | diminished response |
QVPLgPMsYK
|
Nef(73-82) | susceptible form |
QVPLRPMaYK
|
Nef(73-82) | diminished response |
QVPLRPaTYK
|
Nef(73-82) | diminished response |
aVPLRPMTYK
|
Nef(73-82) | susceptible form |
QaPLRPMTYK
|
Nef(73-82) | susceptible form |
QVaLRPMTYK
|
Nef(73-82) | susceptible form |
QVPaRPMTYK
|
Nef(73-82) | susceptible form |
QVPLRaMTYK
|
Nef(73-82) | susceptible form |
QVPLRPMTaK
|
Nef(73-82) | susceptible form |
QVPLRPMTYa
|
Nef(73-82) | susceptible form |
QVPLRPMTYK
|
Nef(73-82) | A*03:01 human epitope |
QVPLRPMTeK
|
Nef(73-82) | diminished response |
QVPvRPMTYK
|
Nef(73-82) | diminished response |
QVPiRPMTYK
|
Nef(73-82) | diminished response |
QVPLRPMTYq
|
Nef(73-82) | diminished response |
QVPLRPMTrr
|
Nef(73-82) | non-susceptible form |
QVPLRPMTYr
|
Nef(73-82) | non-susceptible form; susceptible form |
hVPLRPMTYK
|
Nef(73-82) | diminished response; susceptible form |
QVPLRPMTYK
|
Nef(73-82) | A*03:01 human epitope |
QVPLRPMTYK
|
Nef(73-82) | A*03:01 human epitope |
QVPLRPMTYK
|
Nef(73-82) | A*03:01 human epitope |
QVPLRPMTYK
|
Nef(73-82) | A*03:01 human epitope |
QVPLRPMTYK
|
Nef(73-82) | A*03:01 human epitope |
QVPLRPMTYK
|
Nef(73-82) | A*03:01 human epitope |
QVPLRPMTYK
|
Nef(73-82) | A*03:01 human epitope |
QVPLRPMTYK{gA}
|
Nef(73-82) | inferred escape |
QVPLRPMTfK{gA}
|
Nef(73-82) | inferred escape |
QVPLRPMTYK
|
Nef(73-82) | A*03:01 human epitope |
QVPLRPMTYK
|
Nef(73-82) | A*03:01, A*11 human epitope |
QiPLRPMTYK
|
Nef(73-82) | diminished HLA binding or increased off-rate; observed variant |
QVPLRPMTYK
|
Nef(73-82) | A*03:01, A11 human, macaque epitope |
QVPLRPMTYK
|
Nef(73-82) | A*03:01, A11 human epitope |
QVPLRPMTYK
|
Nef(73-82) | A03 supertype human epitope |
QVPLRPMTYK
|
Nef(73-82) | A*11 human epitope |
QVPLRPMTYK
|
Nef(73-82) | A*11 human epitope |
QVPLRPMTYK
|
Nef(73-82) | A*11 human epitope |
QVPLRPMTYK
|
Nef(73-82) | A11 human epitope |
QVPLRPMTsr
|
Nef(73-82) | diminished HLA binding or increased off-rate |
{r*}QVPLRPMTYK{g}
|
Nef(73-82) | inferred escape; processing |
QVPLRPMTYK
|
Nef(73-82) | A11 human epitope |
QVPLRPMTYK
|
Nef(73-82) | A11 human epitope |
QVPLRPMTYK
|
Nef(73-82) | A11 human epitope |
QVPLRPMTYK
|
Nef(73-82) | A11 human epitope |
QVPLRPMTYK
|
Nef(73-82) | A11 human epitope |
QVPLRPMTYK
|
Nef(73-82) | A11 human epitope |
QVPLRPMTYK
|
Nef(73-82) | A11 epitope |
QVPLRPMTYK
|
Nef(73-82) | A11 human epitope |
QVPLRPMTYK
|
Nef(73-82) | A11 human epitope |
QVPLRPMTYK
|
Nef(73-82) | A11 human epitope |
QVPLRPMTYK
|
Nef(73-82) | A11 human epitope |
QVPLRPMTYK
|
Nef(73-82) | A11 human epitope |
QVPLRPMTYK
|
Nef(73-82) | A11 human epitope |
QVPLRPMTYK
|
Nef(73-82) | A11 human epitope |
QVPLRPMTYK
|
Nef(73-82) | A11, A2, A3, B35 human epitope |
QVPLRPMTYK
|
Nef(73-82) | A11, A3 human epitope |
QVPLRPMTYK
|
Nef(73-82) | A11, A3 human epitope |
QVPvRPMTYK
|
Nef(73-82) | observed variant |
QVPmRPMTYK
|
Nef(73-82) | observed variant |
QVPLRPMTfK
|
Nef(73-82) | susceptible form |
QVPLRPMTYK
|
Nef(73-82) | A11, A3 human epitope |
QVPLRPMYTK
|
Nef(73-82) | A11, A3 human epitope |
QVPLRPMTYK
|
Nef(73-82) | A11, A3 human epitope |
QVPLRPMTYK
|
Nef(73-82) | A11, A3, A30 epitope |
QVPLRPMTYK
|
Nef(73-82) | A11, A3, B35 human epitope |
QVPLRPMTYK
|
Nef(73-82) | A*11:01 epitope |
QVPLRPMTYK
|
Nef(73-82) | A*11:01 human epitope |
QVPLRPMTYK
|
Nef(73-82) | A*11:01 human epitope |
QVPLRPMTYK
|
Nef(73-82) | A*11:01 human epitope |
QVPLRPMTYK
|
Nef(73-82) | A*11:01 human epitope |
QVPLRPMTYK
|
Nef(73-82) | A*11:01 human epitope |
QVPLRPMTYK
|
Nef(73-82) | A3 human epitope |
QVPLRPMTYK
|
Nef(73-82) | A3 human epitope |
QVPLRPMTYK
|
Nef(73-82) | A3 human epitope |
QVPLRPMTYK
|
Nef(73-82) | A3 human epitope |
QVPLRPMTfK
|
Nef(73-82) | susceptible form |
QVPLkPMTfK
|
Nef(73-82) | diminished response |
QVPLRPMnYK
|
Nef(73-82) | diminished response |
QVPvRPMTfK
|
Nef(73-82) | escape documented in this paper |
QVPLRPMsYr
|
Nef(73-82) | escape documented in this paper |
QVPLRPMsYK
|
Nef(73-82) | susceptible form |
QVPLRPMTYK
|
Nef(73-82) | A3 human epitope |
QVPLRPMTYK
|
Nef(73-82) | A3 human epitope |
QVPLRPMTYK
|
Nef(73-82) | A3 human epitope |
QVPLRPMTYK
|
Nef(73-82) | A3 human epitope |
{k*}QVPLRPMTYK{g}
|
Nef(73-82) | escape documented in this paper; processing |
QVPLRPMTYK
|
Nef(73-82) | A3 human epitope |
QVPLRPMTYK
|
Nef(73-82) | A3 human epitope |
QVPLRRMTYK
|
Nef(73-82) | A3 human epitope |
QVPLRPMTYK
|
Nef(73-82) | A3 human epitope |
QVPLRPMTYK
|
Nef(73-82) | A3 human epitope |
QVPLRPMTYK
|
Nef(73-82) | A3 human epitope |
QVPLRPMTYK
|
Nef(73-82) | A3 human epitope |
QVPLRPMTYK
|
Nef(73-82) | A3 human epitope |
QVPLRPMTYK
|
Nef(73-82) | A3 human epitope |
QVPLRRMTYK
|
Nef(73-82) | A3 human epitope |
QVPLRPMTYK
|
Nef(73-82) | A*33 human epitope |
QVPLRPMTYK
|
Nef(73-82) | A*34 human epitope |
QVPLRPMTYK
|
Nef(73-82) | A3 supertype human epitope |
QVPLRPMTYK
|
Nef(73-82) | A*66 human epitope |
QVPLRPMTYK
|
Nef(73-82) | B*08 human epitope |
QVPLRPMTYK
|
Nef(73-82) | B27 human epitope |
SVPLRPMTYK
|
Nef(73-82) | B35, Cw4 human epitope |
QVPLRPMTYK
|
Nef(73-82) | B*35:02, B*35:03, B*53:01 human epitope |
QVPLRPMTYK
|
Nef(73-82) | B8 human epitope |
SVPLRPMTYK
|
Nef(73-82) | C*04 human epitope |
QVPVRPMTYK
|
Nef(73-82) | C*08 human epitope |
QVPLRPMTYK
|
Nef(73-82) | human epitope |
QVPLRPMTYK
|
Nef(73-82) | human epitope |
QVPLRPMTYK
|
Nef(73-82) | human epitope |
QVPLRPMTYK
|
Nef(73-82) | human epitope |
QVPLRPMTYK
|
Nef(73-82) | human epitope |
QVPLRPMTYKA
|
Nef(73-83) | A3 human epitope |
QVPLRPMTYKAAVDL
|
Nef(73-87) | B57 human epitope |
QVPLRPMTYKAAVDL
|
Nef(73-87) | human epitope |
QVPLRPMTYKAAVDL
|
Nef(73-87) | human epitope |
QVPLRPMTfKAAVDL
|
Nef(73-87) | observed variant |
AVPLRPMTYKAAFDLSFF
|
Nef(73-90) | A*68:02 human epitope |
QVPLRPMTYKGALDLSHF
|
Nef(73-90) | human epitope |
QVPLRPMTYKAAVDLSHF
|
Nef(73-90) | human epitope |
QVPLRPMTYKAAFDLSFFLKEKG
|
Nef(73-95) | human epitope |
VPLRPMTY
|
Nef(74-81) | A*11 human epitope |
VPLRPMTY
|
Nef(74-81) | A3 human epitope |
VPLRPMTY
|
Nef(74-81) | B*07 human epitope |
VPLRPMTY
|
Nef(74-81) | B*35 human epitope |
VPLRPMTY
|
Nef(74-81) | B*35 human epitope |
VPLRPMTY
|
Nef(74-81) | B*35 human epitope |
VPLRPMTY
|
Nef(74-81) | B*35 epitope |
VPLRPMTY
|
Nef(74-81) | B*35 human epitope |
VPLRPMTf
|
Nef(74-81) | literature escape |
VPLRPMTY
|
Nef(74-81) | B*35 human epitope |
VPLRPMTY
|
Nef(74-81) | B*35, B*53 human epitope |
VPLRPMTf
|
Nef(74-81) | escape documented in this paper |
lPLRPMTY
|
Nef(74-81) | observed variant |
VPLRPiTY
|
Nef(74-81) | observed variant |
VPLRPMTt
|
Nef(74-81) | observed variant |
VPLRPMnY
|
Nef(74-81) | observed variant |
VPLRPMTY
|
Nef(74-81) | B*35, B*53:01 human epitope |
VPLRPMTY
|
Nef(74-81) | B35 human epitope |
VPLRPMsY
|
Nef(74-81) | escape documented in this paper |
VPLRPMTf
|
Nef(74-81) | escape documented in this paper |
VPLRPMTY
|
Nef(74-81) | B35 human epitope |
VPLRPMTY
|
Nef(74-81) | B35 human epitope |
VPLRPMTY
|
Nef(74-81) | B35 human epitope |
VPLRPMTY
|
Nef(74-81) | B35 human epitope |
VPLRPMTY
|
Nef(74-81) | B35 human epitope |
VPLRPMTY
|
Nef(74-81) | B35 human epitope |
VPLRPMTY
|
Nef(74-81) | B35 human epitope |
VPLRPMTY
|
Nef(74-81) | B35 human epitope |
VPLRPMTY
|
Nef(74-81) | B35 human, macaque epitope |
VPLRPMTY
|
Nef(74-81) | B35 human epitope |
VPLRPMTY
|
Nef(74-81) | B35 human epitope |
VPLRPMTY
|
Nef(74-81) | B35 human epitope |
VPLRPMTY
|
Nef(74-81) | B35 human epitope |
VPLRPMTY
|
Nef(74-81) | B35 human epitope |
VPLRPMTY
|
Nef(74-81) | B35 human epitope |
VPLRPMTY
|
Nef(74-81) | B35 human epitope |
VPLRPMTY
|
Nef(74-81) | B35 human epitope |
VPLRPMTY
|
Nef(74-81) | B35 human epitope |
VPLRPMTY
|
Nef(74-81) | B35 human epitope |
VPLRPMTY
|
Nef(74-81) | B35 human epitope |
VPLRPMTf
|
Nef(74-81) | escape documented in this paper |
VPLRPMTY
|
Nef(74-81) | B35 human epitope |
VPLRPMTY
|
Nef(74-81) | B35 human epitope |
VPLRPMTY
|
Nef(74-81) | B35, B42 human epitope |
VPLRPMTY
|
Nef(74-81) | B*35:01 human epitope |
VPLRPMTY
|
Nef(74-81) | B*35:01 human epitope |
VPLRPMTY
|
Nef(74-81) | B*35:01 human epitope |
VPvRPMTY
|
Nef(74-81) | observed variant; susceptible form |
VPLRPMTf
|
Nef(74-81) | diminished response; non-susceptible form; TCR related mutation |
VPLRPMTY
|
Nef(74-81) | B*35:01 human epitope |
VPLRPMTf
|
Nef(74-81) | escape documented in this paper |
VPLRPMTY
|
Nef(74-81) | B*35:01 human epitope |
VPLRPMTf
|
Nef(74-81) | diminished response |
VPLRPMTY
|
Nef(74-81) | B*35:01 human epitope |
VPLRPMTF
|
Nef(74-81) | B*35:01 human epitope |
VPLRPMTY
|
Nef(74-81) | B*35:01 human epitope |
VPLRPMTY
|
Nef(74-81) | B*35:01 human epitope |
VPLRPMTY
|
Nef(74-81) | B*35:01 human epitope |
VPLRPMTY
|
Nef(74-81) | B*35:01 human epitope |
VPLRPMTY
|
Nef(74-81) | B*35:01 human epitope |
VPLRPMTY
|
Nef(74-81) | B*35:02, B*35:03, B*53:01 human epitope |
VPLRPMTY
|
Nef(74-81) | B*55 human epitope |
VPLRPMTY
|
Nef(74-81) | B*78 human epitope |
VPLRPMTY
|
Nef(74-81) | B*81 human epitope |
VPLRPMTY
|
Nef(74-81) | C*12 human epitope |
VPLRPMTY
|
Nef(74-81) | human epitope |
VPLRPMTY
|
Nef(74-81) | human epitope |
VPLRPMTYK
|
Nef(74-82) | A11 human epitope |
VPLRPMTFK
|
Nef(74-82) | human epitope |
VPLRPMTYKA
|
Nef(74-83) | B7 human epitope |
VPLRPMTYRAARDLS
|
Nef(74-88) | B7 supertype human epitope |
IPLRPMTYKGALDLS
|
Nef(74-88) | B7 supertype human epitope |
PLRPMTYK
|
Nef(75-82) | A11 human epitope |
PLRPMYTK
|
Nef(75-82) | A11 human epitope |
PLRPMTYK
|
Nef(75-82) | A*11:01 human epitope |
PLRPMTYK
|
Nef(75-82) | A*11:01 human epitope |
PLRPMTYK
|
Nef(75-82) | B*15:01 human epitope |
PLRPMTYK
|
Nef(75-82) | C*02 human epitope |
PLRPMTYKAALDLSH
|
Nef(75-89) | human epitope |
LRPMTYKAA
|
Nef(76-84) | B*27:03 human epitope |
LRPMTYKAA
|
Nef(76-84) | B*27:03 human epitope |
RPMTYKAAL
|
Nef(77-85) | A*32 human epitope |
RPMTYKAAL
|
Nef(77-85) | B*07 human epitope |
RPMTYKAAL
|
Nef(77-85) | B*07 human epitope |
RPMThqAAw
|
Nef(77-85) | diminished response; susceptible form |
RPMTYKAAL
|
Nef(77-85) | B*07 human epitope |
RPMTYKGAL
|
Nef(77-85) | B*07 human epitope |
RPMTYKAAL
|
Nef(77-85) | B*07 human epitope |
RPMTYKAAV
|
Nef(77-85) | B*07 human epitope |
RPMTYKAAL
|
Nef(77-85) | B*07 human epitope |
RPMTYKAAL
|
Nef(77-85) | B*07 human, transgenic mouse epitope |
RPMTYKgAL
|
Nef(77-85) | susceptible form |
RPMTYKAAv
|
Nef(77-85) | susceptible form |
RPMTfKAAL
|
Nef(77-85) | susceptible form |
RPMTYKfAL
|
Nef(77-85) | susceptible form |
RPMTYKAAf
|
Nef(77-85) | susceptible form |
RPMTYKAAV
|
Nef(77-85) | B*07 human epitope |
RPMTYKAAV
|
Nef(77-85) | B*07:02 human epitope |
RPMTYKAAf
|
Nef(77-85) | subtype-specific susceptible form |
RPMTYKAAL
|
Nef(77-85) | B*07:02 human epitope |
RPMTYKAAL
|
Nef(77-85) | B*07:02 human epitope |
RPMTFKGAL
|
Nef(77-85) | B*07:02 human epitope |
RPMTFKaAv
|
Nef(77-85) | diminished response; escape documented in this paper; non-susceptible form |
RPMTFKaAL
|
Nef(77-85) | diminished response; escape documented in this paper; non-susceptible form |
RPMTyKaAi
|
Nef(77-85) | diminished response; escape documented in this paper; non-susceptible form |
RPMTyKaAf
|
Nef(77-85) | diminished response; escape documented in this paper; non-susceptible form |
RPMTyKGAv
|
Nef(77-85) | diminished response; escape documented in this paper; non-susceptible form |
RPMTyKaAv
|
Nef(77-85) | diminished response; escape documented in this paper; non-susceptible form |
RPMTyKaAL
|
Nef(77-85) | diminished response; escape documented in this paper; non-susceptible form |
RPMTyKGAL
|
Nef(77-85) | susceptible form |
RPMTYKGAL
|
Nef(77-85) | B*07:02 human epitope |
RPMTfKGAL
|
Nef(77-85) | inferred escape; literature escape |
RPMTYKGAL
|
Nef(77-85) | B*07:02 human epitope |
RPMTYKaAL
|
Nef(77-85) | diminished response; escape documented in this paper; non-susceptible form; susceptible form |
RPMTYKaAv
|
Nef(77-85) | diminished response; escape documented in this paper; non-susceptible form; susceptible form |
RPMTYKaAf
|
Nef(77-85) | diminished response; escape documented in this paper; susceptible form |
RPMTYKaAi
|
Nef(77-85) | diminished response; escape documented in this paper; susceptible form |
RPMTfKaAL
|
Nef(77-85) | diminished response; escape documented in this paper; non-susceptible form |
RPMTfKaAv
|
Nef(77-85) | diminished response; escape documented in this paper; non-susceptible form |
RPMTYKgAv
|
Nef(77-85) | diminished response; escape documented in this paper; susceptible form |
RPMTYKAAL
|
Nef(77-85) | B*07:02 human epitope |
RPMTFKGAL
|
Nef(77-85) | B*07:02 human epitope |
RPMTYKAAL
|
Nef(77-85) | B*18 human epitope |
RPMTYKAAV
|
Nef(77-85) | B*42:01 human epitope |
RPMTFKGAF
|
Nef(77-85) | B*42:01, B*42:02 human epitope |
RPMTYKAAL
|
Nef(77-85) | B7 human epitope |
RPMTYKAAL
|
Nef(77-85) | B7 human epitope |
RPMTYKAAV
|
Nef(77-85) | B7 human epitope |
RPMTYKAAV
|
Nef(77-85) | B7 human epitope |
RPMTYKAAL
|
Nef(77-85) | B7 human epitope |
RPMTYKAAV
|
Nef(77-85) | B7 human epitope |
RPMTYKAAL
|
Nef(77-85) | B7 human epitope |
RPMTYKAAV
|
Nef(77-85) | B7 human epitope |
RPMTYKGAL
|
Nef(77-85) | B7 human epitope |
RPMTYKaAv
|
Nef(77-85) | observed variant |
RPMTYKaAL
|
Nef(77-85) | observed variant |
RPMTYKAAL
|
Nef(77-85) | B7 human epitope |
RPMTYKAAL
|
Nef(77-85) | B7 human epitope |
RPMTYKAAV
|
Nef(77-85) | B7 human epitope |
RPMTYKAAV
|
Nef(77-85) | B7 human epitope |
RPMTYKAAl
|
Nef(77-85) | observed variant |
RPMTYKgAi
|
Nef(77-85) | non-susceptible form; susceptible form |
RPMTYKgAl
|
Nef(77-85) | observed variant |
RPMTYKgAf
|
Nef(77-85) | observed variant |
RPMTfKgAf
|
Nef(77-85) | observed variant |
RPMTfKAAV
|
Nef(77-85) | observed variant |
RPMTYKeAV
|
Nef(77-85) | observed variant |
RPMTYKGAL
|
Nef(77-85) | B7 human epitope |
RPMTYKGAL
|
Nef(77-85) | B7 human epitope |
RPMTYrGAL
|
Nef(77-85) | observed variant |
RPMTYKaAL
|
Nef(77-85) | observed variant |
RPMTYKGAv
|
Nef(77-85) | observed variant |
RPMsYKaAL
|
Nef(77-85) | observed variant |
RPMTfKGAL
|
Nef(77-85) | observed variant |
RPMTYKGAL
|
Nef(77-85) | B7 supertype human epitope |
RPMTYraAr
|
Nef(77-85) | susceptible form |
RPMTYKAAL
|
Nef(77-85) | B*81 human epitope |
RPMTYKAAV
|
Nef(77-85) | B*82 human epitope |
RPMTYKAAL
|
Nef(77-85) | B*82 human epitope |
RPMTYKAAV
|
Nef(77-85) | C*08 human epitope |
RPMTYKAAL
|
Nef(77-85) | C*17 human epitope |
RPMTYKAAV
|
Nef(77-85) | human epitope |
RPMTYKGAL
|
Nef(77-85) | human epitope |
RPMTYKAAV
|
Nef(77-85) | human epitope |
RPMTWKGAL
|
Nef(77-85) | human epitope |
RPMTWKAAL
|
Nef(77-85) | susceptible form |
RPMTYKGAL
|
Nef(77-85) | susceptible form |
RPMTRKAAL
|
Nef(77-85) | susceptible form |
RPMTCKGAL
|
Nef(77-85) | susceptible form |
RPMTYKAAL
|
Nef(77-85) | observed variant |
RPITYKAAL
|
Nef(77-85) | susceptible form |
RPMTYKAAV
|
Nef(77-85) | human epitope |
RPMTYKAALDLSHFL
|
Nef(77-91) | B62 human epitope |
RPMTYKGAVDLSHFL
|
Nef(77-91) | B62 human epitope |
RPMTYKAAVDLSHFL
|
Nef(77-91) | human epitope |
RPMTfKAAVDLSHFL
|
Nef(77-91) | observed variant |
RPMTYKGAFDLSFFL
|
Nef(77-91) | human epitope |
RPMTYKAAVDLSHFLK
|
Nef(77-92) | A*02:01 human epitope |
PMTYKAAVDLSHFLK
|
Nef(78-92) | A3 human epitope |
PMTYKAAVDLSHFLK
|
Nef(78-92) | B62 human epitope |
PMTYKGAFDLSHFLK
|
Nef(78-92) | B62 human epitope |
MTYKAALDL
|
Nef(79-87) | A*02:01 mouse epitope |
MTYKAAFDL
|
Nef(79-87) | A*02:01 human epitope |
MTYKAALDL
|
Nef(79-87) | A2 human, humanized mouse epitope |
MTYKAAVDL
|
Nef(79-87) | B63 human epitope |
MTYKGALDL
|
Nef(79-87) | human epitope |
MTYKAALDLSHFLK
|
Nef(79-92) | human epitope |
MTYKGAFDLSHFLKE
|
Nef(79-93) | human epitope |